Concentration matters in newer urinalysis techniques

Article

In a retrospective study of 27,000 infants aged younger than 3 months evaluated for urinary tract infection (UTI) with paired urinalysis and urine culture, investigators set out to determine the optimal urine white blood cell (WBC) threshold for UTI when using an automated urinalysis system stratified by urine concentration.

In newer urinalysis techniques, concentration matters. In a retrospective study of 27,000 infants aged younger than 3 months evaluated for urinary tract infection (UTI) with paired urinalysis and urine culture, investigators set out to determine the optimal urine white blood cell (WBC) threshold for UTI when using an automated urinalysis system stratified by urine concentration. Based on their analysis of the data, the authors recommend using pyuria thresholds of 3 WBC/high-power field (HPF) in dilute urine (specific gravity, <1.015) and 6 WBC/HPF in concentrated urine (specific gravity, >1.015) for a presumptive diagnosis of UTI. They also note that positive leukocyte esterase by automated dipstick is a strong indicator of UTI (Chaudhari PP, et al. Pediatrics. 2016;138[5]:e20162370).

Next: Overweight is not treated in children hospitalized with asthma

Ms Freedman is a freelance medical editor and writer in New Jersey. She has nothing to disclose in regard to affiliations with or financial interests in any organizations that may have an interest in any part of this article.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
How fragrance plays a role in atopic dermatitis treatments, with John Browning, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
© 2025 MJH Life Sciences

All rights reserved.